Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.95 |
| ▸ | ESR1 | P03372 | 2/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | TACR2 | P21452 | 2/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | SHBG | P04278 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 1/20 | 0.63 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | TST | Q16762 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11737365 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| Cardol SCHEMBL406402 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL2464812 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL4448056 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL16432840 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL1914183 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL16431835 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL17201654 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL2468227 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 | |
| SCHEMBL2178058 | 1.00 | PTGS2 (1.00) | PTGS2CYP3A4ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606508-B2 | Cannabis extracts and uses thereof | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2026-04-21 | — | — | US | claimed |
| WO-2025062311-A2 | A METHOD OF MANUFACTURING PRECURSOR COMPOUNDS FOR MANUFACTURING CANNABINOIDS AND/OR METHODS OF MANUFACTURING CANNABINOIDS | UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG (ZA) | 2025-03-27 | — | — | WO | claimed |
| US-20240109830-A1 | CANNABIS EXTRACTS AND USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2024-04-04 | — | — | US | claimed |
| US-20230313154-A1 | PRENYLTRANSFERASE ENZYMES | CB THERAPEUTICS, INC. (US) | 2023-10-05 | — | — | US | claimed |
| US-20230029027-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. | 2023-01-26 | — | — | US | claimed |
| US-20220064090-A1 | CANNABIS EXTRACTS AND USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (36% + 7%) (IT) | 2022-03-03 | — | — | US | claimed |
| WO-2020210810-A9 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2020-11-26 | — | — | WO | claimed |
| WO-2020210810-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2020-10-15 | — | — | WO | claimed |
| WO-2019183152-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2019-09-26 | — | — | WO | claimed |
| EP-2087022-A1 | MODIFIED ALKYLRESORCINOL RESINS AND APPLICATIONS THEREOF | INDSPEC CHEMICAL CORPORATION (US) | 2009-08-12 | — | — | EP | claimed |
| WO-2008048839-A1 | MODIFIED ALKYLRESORCINOL RESINS AND APPLICATIONS THEREOF | INDSPEC CHEMICAL CORPORATION (US) | 2008-04-24 | — | — | WO | claimed |
| US-20070048664-A1 | Coating formulation for limited play data storage media | SABIC INNOVATIVE PLASTICS IP B.V. | 2007-03-01 | — | — | US | claimed |
| EP-1500097-A2 | COATING FORMULATIONS FOR LIMITED PLAY DATA STORAGE MEDIA | GENERAL ELECTRIC COMPANY (US) | 2005-01-26 | — | — | EP | claimed |
| US-20040014859-A1 | Coating formulations for limited play data storage media | GENERAL ELECTRIC COMPANY | 2004-01-22 | — | — | US | claimed |
| WO-2003089528-A2 | COATING FORMULATIONS FOR DATA STORAGE MEDIA | GENERAL ELECTRIC COMPANY (US) | 2003-10-30 | — | — | WO | claimed |
| US-5386019-A | Reacting a sugar glycal with a 2,4-dihydroxybenzoic acid derivative, and combining the aryl glycoside formed with a suitable aryl compound | YALE UNIVERSITY (US) | 1995-01-31 | — | — | US | claimed |
| WO-1993014099-A1 | SYNTHESIS OF INHIBITORS OF CALMODULIN-MEDIATED ENZYMES | YALE UNIVERSITY (US) | 1993-07-22 | — | — | WO | claimed |
| US-12606508-B2 | Cannabis extracts and uses thereof | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2026-04-21 | — | — | US | disclosed |
| US-3960871-A | ANTIDEPRESSANT, ANALGESICS, ANTICONVULSANT ANTI-ANXIETY ACTIVITY | SHARPS ASSOCIATES (US) | 1976-06-01 | — | — | US | disclosed |
| US-3940421-A | Intermediates for the preparation of thienobenzopyrans and thiopyranobenzopyrans | ARTHUR D. LITTLE, INC. (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064090-A1 | CANNABIS EXTRACTS AND USES THEREOF | CNR1, CNR2, FAAH | PTGS2 1807/4885CYP3A4 1187/4885ESR1 1281/4885 |
| US-12606508-B2 | Cannabis extracts and uses thereof | CNR1, CNR2, FAAH | PTGS2 810/4885CYP3A4 618/4885ESR1 935/4885 |
| US-20240109830-A1 | CANNABIS EXTRACTS AND USES THEREOF | CNR1, CNR2, FAAH | PTGS2 1885/4885CYP3A4 1193/4885ESR1 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.